Bafetinib (INNO-406) structure
|
Common Name | Bafetinib (INNO-406) | ||
---|---|---|---|---|
CAS Number | 859212-16-1 | Molecular Weight | 576.615 | |
Density | 1.4±0.1 g/cm3 | Boiling Point | N/A | |
Molecular Formula | C30H31F3N8O | Melting Point | 166-168°C | |
MSDS | N/A | Flash Point | N/A |
Use of Bafetinib (INNO-406)Bafetinib is a Lyn and Bcr-Abl tyrosine kinase inhibitor with potential antineoplastic activity. |
Name | Bafetinib(INNO 406,NS 187) |
---|---|
Synonym | More Synonyms |
Description | Bafetinib is a Lyn and Bcr-Abl tyrosine kinase inhibitor with potential antineoplastic activity. |
---|---|
Related Catalog | |
References |
Density | 1.4±0.1 g/cm3 |
---|---|
Melting Point | 166-168°C |
Molecular Formula | C30H31F3N8O |
Molecular Weight | 576.615 |
Exact Mass | 576.257263 |
PSA | 99.17000 |
LogP | 3.03 |
Index of Refraction | 1.640 |
Storage condition | Refrigerator |
Benzamide, N-[3-([5,5'-bipyrimidin]-2-ylamino)-4-methylphenyl]-4-[[(3S)-3-(dimethylamino)-1-pyrrolidinyl]methyl]-3-(trifluoromethyl)- |
N-[3-(5,5'-Bipyrimidin-2-ylamino)-4-methylphenyl]-4-{[(3S)-3-(dimethylamino)-1-pyrrolidinyl]methyl}-3-(trifluoromethyl)benzamide |
Benzamide, N-[3-([4,5'-bipyrimidin]-2-ylamino)-4-methylphenyl]-4-[[(3S)-3-(dimethylamino)-1-pyrrolidinyl]methyl]-3-(trifluoromethyl)- |
Bafetinib |
Bafetinib (INNO-406) |
N-[3-(4,5'-Bipyrimidin-2-ylamino)-4-methylphenyl]-4-{[(3S)-3-(dimethylamino)-1-pyrrolidinyl]methyl}-3-(trifluoromethyl)benzamide |